365 related articles for article (PubMed ID: 20964743)
1. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
2. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
3. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
Costa MJ; Kenny MB; Naib ZM
Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
[TBL] [Abstract][Full Text] [Related]
4. Isthmic-vaginal smear cytology in the follow-up after radical vaginal trachelectomy for early stage cervical cancer: is it safe?
Lanowska M; Mangler M; Grittner U; Akbar GR; Speiser D; von Tucher E; Köhler C; Schneider A; Kühn W
Cancer Cytopathol; 2014 May; 122(5):349-58. PubMed ID: 24478265
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
7. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
8. [Cervical cancer in the young woman].
Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
[TBL] [Abstract][Full Text] [Related]
9. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
Coleman DV; Poznansky JJ
Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
[TBL] [Abstract][Full Text] [Related]
10. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
11. Cytology, liquid-based cytology and automation.
Smith JH
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):585-96. PubMed ID: 21632286
[TBL] [Abstract][Full Text] [Related]
12. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
13. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
14. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia.
Takac I; Ursic-Vrscaj M; Repse-Fokter A; Kodric T; Rakar S; Mozina A; Smrkolj S; Primic-Zakelj M; Strzinar V; Vakselj A; Arko D
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):82-9. PubMed ID: 18400358
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
17. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
[TBL] [Abstract][Full Text] [Related]
18. [Reevaluation for overlooked signs of cervical smears in cases of uterine cervical adenocarcinoma].
Kutsuzawa T; Yamada Y; Ishizaki Y; Sato C; Kaneko M; Moriya S; Ichinoe K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2598-604. PubMed ID: 6520480
[TBL] [Abstract][Full Text] [Related]
19. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
